Furthermore, we show that the AAV form of ETV2 is as efficient as lentiviral ETV2 in a murine model of MI, raising the possibility of using ETV2 as a promising therapeutic agent for the treatment of MI patients. Here, ETV2 is linked to myocardial infarction.